We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000728:SZSEGuoyuan Securities Company Limited Analysis

Data as of 2026-03-07 - not real-time

CN¥7.97

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Guoyuan Securities is trading at ¥7.97, which sits above its DCF‑derived fair value of ¥7.17, indicating a near‑term pricing premium. The stock has slipped below its 20‑day (¥8.20), 50‑day (¥8.36) and 200‑day (¥8.43) simple moving averages, a classic bearish signal. Momentum metrics reinforce the downside bias: the MACD histogram is negative (‑0.037) and the RSI rests at 36, suggesting limited upside momentum. Volume trends are weakening, with a “decreasing” volume pattern despite an average 10‑day volume of ~28 M shares, hinting at waning buying interest. On the valuation front, the PE of 13 is below the industry average of 17.5, and the P/B of 0.93 is under 1, reflecting a value‑oriented pricing profile.
Fundamentally, revenue growth is modest at 2.3% and ROE is only 7.4%, while the balance sheet carries a high debt‑to‑equity ratio of 252, flagging financial leverage risk. Nonetheless, the company generates strong cash flow (operating cash flow ¥4.45 bn) and maintains a dividend yield of 2.26% with a modest payout ratio of 16%, supporting dividend sustainability. The beta of ~0.2 (computed) and a 30‑day volatility of 18% suggest limited systematic risk but noticeable price swings. The overall risk landscape is tempered by a solid market cap of ¥34.8 bn and a “Greed” sentiment index (68.8), yet regulatory and geographic exposures in China remain material. Given the bearish technical backdrop, elevated leverage, and a price that exceeds intrinsic value, the near‑term outlook leans toward downside, while the dividend and value metrics provide a modest floor for longer horizons.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below all major SMAs
  • bearish MACD and low RSI
  • proximity to support level and decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • dividend yield 2.26% with low payout
  • PE below industry average
  • high debt-to-equity constrains upside

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • sustainable dividend despite leverage
  • value-oriented valuation metrics
  • regulatory environment may limit growth

Key Metrics & Analysis

Financial Health

Revenue Growth2.30%
Profit Margin30.42%
P/E Ratio13.1
ROE7.36%
ROA1.58%
Debt/Equity251.72
P/B Ratio0.9
Op. Cash FlowCN¥4.4B
Free Cash FlowCN¥0
Industry P/E17.5

Technical Analysis

TrendBearish
RSI36.6
SupportCN¥7.83
ResistanceCN¥8.53
MA 20CN¥8.20
MA 50CN¥8.36
MA 200CN¥8.43
MACDBearish
VolumeDecreasing
Fear & Greed Index68.77

Valuation

Fair ValueCN¥7.17
Target PriceCN¥10.77
Upside/Downside35.13%
GradeOvervalued
TypeValue
Dividend Yield2.26%

Risk Assessment

Beta0.20
Volatility18.15%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.